• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗天使综合征神经表现的方法。

Therapeutic approach to neurological manifestations of Angelman syndrome.

机构信息

Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.

Regional Epilepsy Centre, Great Metropolitan Hospital "Bianchi-Melacrino-Morelli", Reggio, Calabria, Italy.

出版信息

Expert Rev Clin Pharmacol. 2022 Jul;15(7):843-850. doi: 10.1080/17512433.2022.2109463. Epub 2022 Aug 10.

DOI:10.1080/17512433.2022.2109463
PMID:35917229
Abstract

INTRODUCTION

Angelman syndrome (AS) is a neurogenetic disorder due to deficient expression of the maternal copy of the UBE3A gene, which encodes ubiquitin ligase E3A protein. Severe developmental delay, seizures and other neurological disorders characterize AS.

AREAS COVERED

In this review, we focus on a comprehensive therapeutic approach to the most disabling neurological manifestations of AS: epilepsy, sleep disturbances, behavioral and movement disorders. Articles were identified through PubMed and Google Scholar up to October 2021.

EXPERT OPINION

Evidence for the treatment of neurological manifestations in AS mainly derives from poor quality studies (case reports, small case series, expert opinions). Seizures can be polymorphic and includes atypical absences, myoclonic, generalized tonic-clonic, unilateral clonic, or atonic attacks. Sodium valproate, levetiracetam, and benzodiazepines are the most commonly used anti-seizure medications. Melatonin or mirtazapine seem to improve sleep quality. Antipsychotics, antidepressants, and anxiolytics have been proposed for the treatment of behavioral manifestations, but no evidence-based studies are available. Non-pharmacological approach may also be useful. Mild dystonia is common but usually does not significantly impact patients' motor performances. Well-conducted clinical trials aimed to evaluate treatment of neurological complications of AS are warranted. Gene and molecular precision therapies represent a fascinating area of research in the future.

摘要

简介

天使综合征(AS)是一种神经遗传疾病,由于母源 UBE3A 基因表达缺陷,导致泛素连接酶 E3A 蛋白缺失。严重的发育迟缓、癫痫发作和其他神经功能障碍是 AS 的特征。

涵盖领域

在这篇综述中,我们重点关注对 AS 最具致残性的神经表现的全面治疗方法:癫痫、睡眠障碍、行为和运动障碍。文章通过 PubMed 和 Google Scholar 检索至 2021 年 10 月。

专家意见

AS 神经表现治疗的证据主要来自低质量研究(病例报告、小病例系列、专家意见)。癫痫发作可能呈多形性,包括非典型失神发作、肌阵挛发作、全面强直-阵挛发作、单侧阵挛发作或强直-阵挛发作。丙戊酸钠、左乙拉西坦和苯二氮䓬类药物是最常用的抗癫痫药物。褪黑素或米氮平似乎可以改善睡眠质量。抗精神病药、抗抑郁药和抗焦虑药已被提议用于治疗行为表现,但目前尚无基于证据的研究。非药物治疗方法也可能有用。轻度的肌张力障碍很常见,但通常不会显著影响患者的运动表现。需要进行精心设计的临床试验,以评估 AS 神经并发症的治疗方法。基因和分子精准治疗代表了未来一个引人入胜的研究领域。

相似文献

1
Therapeutic approach to neurological manifestations of Angelman syndrome.治疗天使综合征神经表现的方法。
Expert Rev Clin Pharmacol. 2022 Jul;15(7):843-850. doi: 10.1080/17512433.2022.2109463. Epub 2022 Aug 10.
2
Epilepsy in Angelman syndrome: A scoping review.天使综合征中的癫痫:范围综述。
Brain Dev. 2021 Jan;43(1):32-44. doi: 10.1016/j.braindev.2020.08.014. Epub 2020 Sep 4.
3
Neural hyperexcitability in Angelman syndrome: Genetic factors and pharmacologic treatment approaches.天使综合征中的神经兴奋性过高:遗传因素与药物治疗方法
Epilepsy Res. 2024 Feb;200:107286. doi: 10.1016/j.eplepsyres.2024.107286. Epub 2024 Jan 5.
4
Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options.天使综合征中的癫痫:基于问卷调查对自然病史及当前治疗选择的评估
Epilepsia. 2009 Nov;50(11):2369-76. doi: 10.1111/j.1528-1167.2009.02108.x. Epub 2009 May 12.
5
Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.丙戊酸钠与苯妥英钠单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2018 Aug 9;8(8):CD001769. doi: 10.1002/14651858.CD001769.pub4.
6
Episodic tremors representing cortical myoclonus are characteristic in Angelman syndrome due to UBE3A mutations.由UBE3A突变导致的天使综合征的特征是出现代表皮质肌阵挛的发作性震颤。
Brain Dev. 2015 Feb;37(2):216-22. doi: 10.1016/j.braindev.2014.04.005. Epub 2014 May 3.
7
Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital.安格曼综合征的癫痫治疗:来自麻省总医院安格曼综合征诊所的病例系列。
Epilepsy Behav. 2016 Jul;60:138-141. doi: 10.1016/j.yebeh.2016.04.030. Epub 2016 May 18.
8
Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman syndrome.37例经分子诊断为天使综合征患者的癫痫特征分析。
Epileptic Disord. 2005 Mar;7(1):19-25.
9
Epilepsy in patients with angelman syndrome caused by deletion of the chromosome 15q11-13.由15号染色体q11 - 13缺失引起的天使综合征患者的癫痫
Arch Neurol. 2006 Jan;63(1):122-8. doi: 10.1001/archneur.63.1.122.
10
Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.苯妥英钠与丙戊酸单药治疗部分性发作和全面性强直阵挛发作的对比
Cochrane Database Syst Rev. 2001(4):CD001769. doi: 10.1002/14651858.CD001769.

引用本文的文献

1
Unveiling Niaprazine's Potential: Behavioral Insights into a Re-Emerging Anxiolytic Agent.揭示尼亚拉嗪的潜力:对一种重新出现的抗焦虑药物的行为学见解。
Biomedicines. 2024 Sep 12;12(9):2087. doi: 10.3390/biomedicines12092087.
2
Sleep disturbance in Angelman syndrome patients.安格曼综合征患者的睡眠障碍。
Orphanet J Rare Dis. 2024 Apr 5;19(1):146. doi: 10.1186/s13023-024-03154-5.
3
Prader-Willi and Angelman Syndromes: Mechanisms and Management.普拉德-威利综合征和安吉尔曼综合征:发病机制与治疗
Appl Clin Genet. 2023 Apr 6;16:41-52. doi: 10.2147/TACG.S372708. eCollection 2023.